Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Protein YKL-40 in multiple myeloma; Ph.D

Research output: Book/ReportPh.D. thesisResearch

  1. Chemerin is elevated in multiple myeloma patients and is expressed by stromal cells and pre-adipocytes

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Serum YKL-40: a new independent prognostic marker for skeletal complications in patients with multiple myeloma

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. N-terminal pro-C-type natriuretic peptide in serum associated with bone destruction in patients with multiple myeloma

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Original languageEnglish
PublisherEget Forlag
ISBN (Print)ISBN 978-87-7611-438-1
Publication statusPublished - 2011

ID: 33274206